SPR Therapeutics, Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$12.7M
Doctors Paid
7,852
Transactions
24,160
2024 Total
$2.8M
Payment Breakdown by Category
Research$8.3M (65.6%)
Consulting$2.4M (18.5%)
Food & Beverage$1.4M (10.7%)
Travel$655,718 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8.3M | 873 | 65.6% |
| Consulting Fee | $2.4M | 641 | 18.5% |
| Food and Beverage | $1.4M | 21,380 | 10.7% |
| Travel and Lodging | $655,718 | 1,264 | 5.2% |
| Charitable Contribution | $4,900 | 1 | 0.0% |
| Honoraria | $2,800 | 1 | 0.0% |
Payments by Type
Research
$8.3M
603 transactions
General
$4.4M
23,287 transactions
Ownership
$0
270 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Randomized, Controlled, Multicenter Trial of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain | $3.2M | 0 | 252 |
| A Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Back Pain | $925,968 | 0 | 30 |
| Treatment of Post-Operative Pain Following Orthopedic Surgery with SPRINT Peripheral Nerve Stimulation (PNS) System in a Randomized, Double-Blinded, Placebo-Controlled Trial | $764,870 | 0 | 42 |
| The SNAP Trial: SPRINT peripheral nerve stimulation for the treatment of Neuropathic post-Amputation Pain in a randomized, double-blinded, placebo-controlled, multicenter trial | $687,892 | 0 | 40 |
| A Prospective Case Series Study of SPR peripheral nerve stimulation (PNS) therapy for the treatment of pain following total knee arthroplasty (TKA) utilizing preoperative lead placement | $472,537 | 0 | 16 |
| Treatment of Post-Operative Pain Following Orthopedic Surgery with SPRINT Peripheral Nerve Stimulation (PNS) System in a Randomized, Double-blind, Placebo-Controlled Trial | $389,675 | 0 | 43 |
| The MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Case Series Study: Treatment of Head Pain with the SPRINT Peripheral Nerve Stimulation | $354,486 | 0 | 53 |
| Treatment of head pain with the SPRINT Peripheral Nerve Stimulation (PNS) System | $278,635 | 0 | 41 |
| A Prospective Case Series Study of SPR peripheral nerve stimulation PNS therapy for the treatment of pain following total knee arthroplasty TKA utilizing preoperative lead placement | $215,124 | 0 | 2 |
| The SNAP Trial SPRINT peripheral nerve stimulation for the treatment of Neuropathic post Amputation Pain in a randomized double blinded placebo controlled multicenter trial | $202,890 | 0 | 5 |
| Ilfeld DOD Phase 1 | $135,224 | 0 | 6 |
| Retrospective Review of the SPRINT PNS System for the Treatment of Chronic Shoulder Pain | $115,635 | 0 | 12 |
| A Randomized, Double-Blinded, Placebo-Controlled, Multicenter Pilot Study of the SPRINT Peripheral Nerve Stimulation (PNS) System for the Treatment of Post-Amputation Pain | $84,750 | 0 | 5 |
| A Randomized Double Blinded Placebo Controlled Multicenter Pilot Study of the SPRINT Peripheral Nerve Stimulation (PNS) System for the Treatment of Post Amputation Pain | $74,518 | 0 | 3 |
| A randomized double blinded placebo controlled multicenter pilot study of the SPRINT PNS System for the treatment of post amputation pain | $70,524 | 0 | 3 |
| Percutaneous Peripheral Neuromodulation for Post-operative Analgesia | $62,382 | 0 | 2 |
| The SNAP Trial: SPRINT peripheral nerve stimulation for the treatment of Neuropathic post-Amputation Pain in a randomized, double-blind, placebo-controlled, multicenter trial | $56,850 | 0 | 2 |
| PNS for SIS 1RO1HD093661-01A1 | $44,401 | 0 | 6 |
| Multi-Modal Treatment for HSP RO1HD084564 | $41,853 | 0 | 8 |
| A Pilot Study of Return Electrode Configuration of SPRINT Percutaneous Peripheral Nerve Stimulation (PNS) | $41,260 | 0 | 16 |
| Treatment of Post Operative Pain Following Orthopedic Surgery with SPRINT Peripheral Nerve Stimulation (PNS) System in a Randomized Double Blinded Placebo Controlled Trial | $22,596 | 0 | 2 |
| A Post-Market Observational Case Series Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Shoulder Pain | $22,410 | 0 | 1 |
| Exploring the benefit of peripheral nerve stimulation in treating pain from chemo-induced peripheral neuropathy: A Longitudinal Single Center Feasibility Study | $18,850 | 0 | 1 |
| Ilfeld DOD Phase 2 | $14,246 | 0 | 1 |
| A Study of Percutaneous Peripheral Nerve Stimulation PNS for the Treatment of Back Pain | $7,000 | 0 | 1 |
| Treatment of Back Pain | $6,577 | 0 | 1 |
| PNS fo Shoulder Pain Dose Response RO1HD075542 | $5,723 | 0 | 2 |
| A Post-Market Study of Percutaneous Peripheral Nerve Stimulation (PNS) for the | $4,500 | 0 | 3 |
| A randomized double blinded placebo controlled multicenter pivotal study of the SMARTPATCH PNS System for the treatment of chronic post stroke shoulder pain | $4,250 | 0 | 1 |
| Effect of Postoperative Percutaneous PNS on Acute and Chronic Postamputation Pain | $3,761 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 315
No doctor payment records found.
Ad
Top Products
- SPRINT PNS System $12.7M
Associated Products (1)
- SPRINT PNS System $12.7M
Payment Categories
- Food & Beverage $1.4M
- Consulting $2.4M
- Travel & Lodging $655,718
- Research $8.3M
About SPR Therapeutics, Inc
SPR Therapeutics, Inc has made $12.7M in payments to 7,852 healthcare providers, recorded across 24,160 transactions in the CMS Open Payments database. In 2024, the company paid $2.8M. The top product by payment volume is SPRINT PNS System ($12.7M).
Payments were distributed across 135 medical specialties. The top specialty by payment amount is Pain Medicine ($2.1M to 1,582 doctors).
Payment categories include: Food & Beverage ($1.4M), Consulting ($2.4M), Research ($8.3M), Travel & Lodging ($655,718).
SPR Therapeutics, Inc is associated with 1 products in the CMS Open Payments database.